This opportunity is no longer accepting applications.
grant PAR-24-173

NHLBI Early Phase Clinical Trials for Therapeutics and/or Diagnostics for HLBS Disorders (R61/R33 Clinical Trial Required)

This grant opportunity supports Phase I clinical trials for developing diagnostics and treatments for heart, lung, blood, and sleep disorders in both adults and children. It covers both trial start-up and implementation, as well as final preclinical activities necessary for trial readiness. The grant is structured in two phases; the first phase focuses on completing essential pre-trial tasks l…

The objective of this funding opportunity is to support investigator-initiated, Phase I clinical trials for diagnostic and therapeutic interventions for heart, lung, blood, and sleep (HLBS) disorders in adults and children. In addition to supporting clinical trial start-up and implementation act…

Funding Source

Agency: National Institutes of Health
Sub-agency: National Heart, Lung, and Blood Institute
Program: SBIR

Dates

Opportunity Released: April 2, 2024
Open for Submission: April 2, 2024
Submission Deadline: January 7, 2027
Application Window Closes: January 7, 2027

Supporting links

Secure Grant Funding 10x Faster

Scout delivers AI-powered grant writing paired with experts that's faster, more affordable, and built to win.

Already have an account? Sign In

Trusted by 500+ Happy Customers

Get opportunities sent to your inbox

The latest grant news and insights from our experts.

Save this opportunity and explore more

Share Opportunity

Share this opportunity with others.
Anyone with this link can view the opportunity details.